Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 20;2010(1):CD007916.
doi: 10.1002/14651858.CD007916.pub2.

Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns

Mohamed E Abdel-Latif  1 , David A Osborn, Daniel Challis
Affiliations

Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns

Mohamed E Abdel-Latif et al. Cochrane Database Syst Rev. .

Abstract

Background: Early surfactant reduces mortality and pulmonary complications in preterm infants with respiratory distress syndrome. However, current surfactant administration strategies require endotracheal intubation with or without continued mechanical ventilation. Bronchopulmonary dysplasia and chronic lung disease (CLD) are associated with mechanical ventilation and potentially life-long effects. Non-invasive methods of surfactant administration including intra-amniotic surfactant may avoid endotracheal intubation and mechanical ventilation, potentially preventing development of CLD.

Objectives: To determine if intra-amniotic instillation of surfactant for women at risk of preterm birth, compared to placebo or no treatment or post-delivery tracheal surfactant instillation, reduces morbidity or mortality, or both, in preterm infants. If intra-amniotic instillation is effective, in subgroup analysis to determine the effect of 1) gestational age; 2) type of surfactant; 3) dose; 4) timing; 5) indication; and 6) multiple pregnancy.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (August 2009), MEDLINE (1950-August 2009), handsearched the Proceedings of Pediatric Academic Societies (American Pediatric Society, Society for Pediatric Research and European Society for Pediatric Research) from 1990-2009 in Pediatric Research Journal and Abstracts online and the Proceedings of Perinatal Society of Australia and New Zealand (PSANZ) (1996-2009). We also searched the Science Citation Index (Web of Science) (August 2009) and checked reference lists of identified studies. We contacted Abbott Laboratories, Inc for unpublished studies.

Selection criteria: Published, unpublished and ongoing randomised controlled, cluster-randomised or quasi-randomised trials of intra-amniotic instillation of surfactant for women at risk of preterm birth, compared to placebo or no treatment or post-delivery tracheal surfactant instillation.

Data collection and analysis: Three review authors independently assessed study eligibility and quality.

Main results: We found no trials were found met the inclusion criteria for this review.

Authors' conclusions: We identified no randomised trials that evaluated the effect of intra-amniotic instillation of surfactant for women at risk of preterm birth. Evidence from animal and observational human studies suggest that intra-amniotic surfactant administration is potentially safe, feasible and effective. Well designed trials of intra-amniotic instillation of surfactant for women at risk of preterm birth are needed.

PubMed Disclaimer

Conflict of interest statement

None known.

Comment in

References

References to studies excluded from this review

Zhang 2004 {published data only}
    1. Zhang JP, Wang YL, Wang YH, Zhang R, Chen H, Su HB. Prophylaxis of neonatal respiratory distress syndrome by intra‐amniotic administration of pulmonary surfactant. Chinese Medical Journal 2004;117(1):120‐4. - PubMed

Additional references

Aly 2001
    1. Aly HZ. Nasal prongs continuous positive airway pressure: a simple yet powerful tool. Pediatrics 2001;108:759‐61. - PubMed
Bhandari 2007
    1. Bhandari V, Gavino RG, Nedrelow JH, Pallela P, Salvador A, Ehrenkranz RA, et al. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. Journal of Perinatology 2007;27:697‐703. - PubMed
Bhuta 1998
    1. Bhuta T, Henderson‐Smart DJ. Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD000438] - DOI - PMC - PubMed
Björklund 1997
    1. Björklund LJ, Ingimarsson J, Curstedt T, John J, Robertson B, Werner O, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatric Research 1997;42(3):348‐55. - PubMed
Bolisetty 2006
    1. Bolisetty S, Bajuk B, Abdel‐Latif ME, Vincent T, Sutton L, Lui K, et al. Preterm outcome table (POT): a simple tool to aid counseling parents of very preterm infants. Australian and New Zealand Journal of Obstetrics and Gynaecology 2006;46(3):189‐92. - PubMed
Chye 1995
    1. Chye JK, Gray PH. Rehospitalization and growth of infants with bronchopulmonary dysplasia: a matched control study. Journal of Paediatrics and Child Health 1995;31:105‐11. - PubMed
Cosmi 1996a
    1. Cosmi EV, Torre R, lorio R, Anceschi MM. A novel treatment of fetal lung immaturity [abstract]. American Journal of Obstetrics and Gynecology 1996;174(1 Pt 2):487.
Cosmi 1996b
    1. Cosmi EV, Torre R, lorio R, Anceschi MM. Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (IRDS). Journal of Perinatal Medicine 1996;24:191‐3. - PubMed
Cosmi 1996c
    1. Cosmi EV, Torre R, lorio R. Intraamniotic instillation of surfactant for prevention of neonatal respiratory distress syndrome (IRDS): a preliminary report. Applied Cardiopulmonary Pathophysiology 1996;6:3‐5.
Cosmi 1997
    1. Cosmi EV, Torre R, Piazze JJ, Maranghi GL, Lerro N, Bianco D, et al. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience. European Journal of Obstetrics & Gynecology and Reproductive Biology 1997;71:135‐9. - PubMed
Crowther 2007
    1. Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003935.pub2] - DOI - PubMed
Davis 2001
    1. Davis PG, Lemyre B, Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD003212] - DOI - PubMed
Davis 2009
    1. Davis PG, Morley CJ, Owen LS. Non‐invasive respiratory support of preterm neonates with respiratory distress: continuous positive airway pressure and nasal intermittent positive pressure ventilation. Seminars in Fetal & Neonatal Medicine 2009;14:14‐20. - PubMed
Deeks 2001
    1. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta‐analysis in context. London: BMJ Books, 2001.
Deklerk 2001
    1. Deklerk AM, Deklerk RK. Use of continuous positive airway pressure in preterm infants: comments and experience from New Zealand. Pediatrics 2001;108(3):761‐3. - PubMed
Doyle 2006
    1. Doyle LW, Victorian Infant Collaborative Study Group. Respiratory function at age 8‐9 years in extremely low birthweight/very preterm children born in Victoria in 1991‐1992. Pediatric Pulmonology 2006;41(6):570‐6. - PubMed
Duenhoelter 1974
    1. Duenhoelter JH, Pritchard JA. Human fetal respiration. II. Fate of intra‐amniotic hypaque and 51Cr‐labeled red cells. Obstetrics & Gynecology 1974;43(6):878‐83. - PubMed
Fleckonoe 2008
    1. Fleckonoe SJ, Crossley KJ, Lane MA, Allison BJ, Morley CJ, Hooper SB. The effects of mechanical ventilation on airway epithelium in near term and very preterm sheep. Journal of Paediatrics and Child Health 2008;44(1):A42.
Furman 1996
    1. Furman L, Baley J, Borawski‐Clark E, Aucott S, Hack M. Hospitalization as a measure of morbidity among very Iow birth weight infants with chronic lung disease. Journal of Pediatrics 1996;128(4):447‐52. - PubMed
Galan 1992
    1. Galan HL, Kuehl TJ. Effect of intra‐amniotic administration of Exosurf in preterm rabbit fetuses. Obstetrics & Gynecology 1992;80:640‐8. - PubMed
Galan 1993
    1. Galan HL, Cipriani C, Coalson JJ, Bean JD, Collier G, Kuehl TJ. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon. American Journal of Obstetrics and Gynecology 1993;169(4):817‐24. - PubMed
Gortner 1998
    1. Gortner L, Wauer RR, Hammer H, Stock GJ, Heitmann F, Reiter HL, et al. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks gestational age: a multicenter controlled clinical trial. Pediatrics 1998;102:1153‐60. - PubMed
Greenough 2002
    1. Greenough A, Milner AD, Dimitriou G. Synchronized mechanical ventilation for respiratory support in newborn infants. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD000456.pub3] - DOI - PubMed
Grossmann 1986
    1. Grossmann G, Nilsson R, Robertson B. Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung: the prophylactic effect of surfactant replacement. European Journal of Pediatrics 1986;145(5):361‐7. - PubMed
Hallman 1997
    1. Hallman M, Lappalainen U, Bry K. Clearance of intra‐amniotic lung surfactant: uptake and utilization by the fetal rabbit lung. American Journal of Physiology 1997;273(1 Pt 1):L55‐L63. - PubMed
Higgins 2008
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Ho 2002
    1. Ho JJ, Henderson‐Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD002975] - DOI - PMC - PubMed
Hughes 1999
    1. Hughes CA, O'Gorman LA, Shyr Y, Schork MA, Bozynski ME, McCormick MC. Cognitive performance at school age of very low birth weight infants with bronchopulmonary dysplasia. Journal of Developmental and Behavioral Pediatrics 1999;20(1):1‐8. - PubMed
Illia 2004
    1. Illia R, Solana C, Oliveri P, Toblli J, Imaz MU, Häbich D. Evidence of fetal pulmonary aspiration of intra‐amniotic administered surfactant in animal experiment. Journal of Perinatal Medicine 2004;32(4):354‐8. - PubMed
Jobe 2000
    1. Jobe A, Ikegami M. Lung development and function in preterm infants in the surfactant treatment era. Annual Review of Physiology 2000;62:825‐46. - PubMed
Jobe 2001
    1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. American Journal of Respiratory and Critical Care Medicine 2001;163:1723‐9. - PubMed
Jorch 1997
    1. Jorch G, Hartl H, Roth B, Kribs A, Gortner L, Schaible T, et al. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatric Pulmonology 1997;24(3):222‐4. - PubMed
Kalache 1997
    1. Kalache KD, Chaoui R, Bollmann R. Doppler assessment of tracheal and nasal fluid flow during fetal breathing movements: preliminary observations. Ultrasound in Obstetrics and Gynecology 1997;9(4):257‐61. - PubMed
Kattwinkel 2004
    1. Kattwinkel J, Robinson M, Bloom B, Delmore P, Ferguson JE. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. Journal of Perinatology 2004;24:360–5. - PubMed
Kilbride 2003
    1. Kilbride HW, Gelatt MC, Sabath RJ. Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. Journal of Pediatrics 2003;143:488‐93. - PubMed
Korhonen 1999
    1. Korhonen P, Koivisto AM, Ikonen S, Laippala P, Tammela O. Very low birthweight, bronchopulmonary dysplasia and health in early childhood. Acta Paediatrica 1999;88:1385‐91. - PubMed
Kribs 2007
    1. Kribs A, Pillekamp F, Hűsneler C, Vierzig A, Roth B. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age <27 weeks). Paediatric Anaesthesia 2007;17:364‐9. - PubMed
Kugelman 2007
    1. Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. Journal of Pediatrics 2007;150(5):521‐6. - PubMed
Lemyre 2002
    1. Lemyre B, Davis PG, Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD002272] - DOI - PubMed
Lisawa 2003
    1. Lisawa J, Pietrasik D, Zwoliński J, Gierowska‐Bogusz B, Lewandowski L, Chazan B. Doowodniowe podanie surfaktantu jako profilaktyka zespolu zaburzen oddychania‐‐doniesienie wstepne [Intramniotic surfactant supply as RDS prevention]. Medycyna Wieku Rozwojowego 2003;7(3 Suppl 1):255‐60. - PubMed
Majnemer 2000
    1. Majnemer A, Riley P, Shevell M, Birnbaum R, Greenstone H, Coates AL. Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Developmental Medicine and Child Neurology 2000;42:53‐60. - PubMed
McCallion 2005
    1. McCallion N, Davis PG, Morley CJ. Volume‐targeted versus pressure‐limited ventilation in the neonate. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD003666.pub2] - DOI - PubMed
Morley 2008
    1. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, et al. Nasal CPAP or intubation at birth for very preterm infants. New England Journal of Medicine 2008;358:700‐8. - PubMed
O'Shea 1996
    1. O'Shea TM, Goldstein DJ, deRegnier RA, Sheaffer CI, Roberts DD, Dillard RG. Outcome at 4 to 5 years of age in children recovered from neonatal chronic lung disease. Developmental Medicine and Child Neurology 1996;38:830‐9. - PubMed
Petrikovsky 1995
    1. Petrikovsky BM, Lysikiewicz A, Markin LB, Slomko Z. In utero surfactant administration to preterm human fetuses using endoscopy. Fetal Diagnosis and Therapy 1995;10:127‐30. - PubMed
Pollack 2003
    1. Pollack JA, Moise KJ Jr, Tyson WR, Galan HL. The role of fetal breathing motions compared with gasping motions in pulmonary airway uptake of intra‐amniotic iron dextran. American Journal of Obstetrics and Gynecology 2003;189(4):958‐62. - PubMed
Reininger 2005
    1. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. Journal of Perinatology 2005;25(11):703‐8. - PubMed
RevMan 2008 [Computer program]
    1. The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
Roberts 2006
    1. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2] - DOI - PubMed
Seger 2009
    1. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD007836] - DOI - PubMed
Singer 1997
    1. Singer L, Yamashita T, Lilien L, Collin M, Baley J. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics 1997;100:987‐93. - PMC - PubMed
Skidmore 1990
    1. Skidmore MD, Rivers A, Hack M. Increased risk of cerebral palsy among very low‐birthweight infants with chronic lung disease. Developmental Medicine and Child Neurology 1990;32:325‐32. - PubMed
Soll 1998a
    1. Soll R. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 2. [DOI: 10.1002/14651858.CD001079] - DOI - PubMed
Soll 1998b
    1. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 1998, Issue 3. [DOI: 10.1002/14651858.CD001149] - DOI - PMC - PubMed
Soll 1999
    1. Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001456] - DOI - PMC - PubMed
Soll 2001
    1. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000510] - DOI - PubMed
Soll 2001a
    1. Soll R, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000144] - DOI - PubMed
Soll 2001b
    1. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD000510] - DOI - PubMed
Soll 2002
    1. Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD000511] - DOI - PMC - PubMed
Soll 2009
    1. Soll R, Özek E. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD000141.pub2] - DOI - PubMed
Stevens 2007
    1. Stevens TP, Blennow M, Myers EW, Soll R. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews 2007, Issue 4. [DOI: 10.1002/14651858.CD003063.pub3] - DOI - PMC - PubMed
Trevisanuto 2005
    1. Trevisanuto D, Grazzina N, Ferrarese P, Micaglio M, Verghese C, Zanardo V. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biology of the Neonate 2005;87:217–20. - PubMed
Van Marter 2000
    1. Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, et al. Do clinical markers of barotrauma and oxygen toxicity explain inter‐hospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000;105:1194‐201. - PubMed
Zhang 2002
    1. Zhang JP, Wang YL, Liu YL, Mei S. Prevention of neonatal respiratory distress syndrome by intra‐amniotic administration of pulmonary surfactant: a case report. Chinese Journal of Obstetrics and Gynecology 2002;37(4):256.

Publication types

Substances

LinkOut - more resources